This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
111 |
4. Check minimum number of eventsNone |
111 |
5. Include endpointsNone |
111 |
6. Filter based on genotype QC (FinnGen only) |
111 |
Control definitions (FinnGen only)
- Control exclude
- K11_ENERCOLNONINF
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K52
- Name in latin
- Gastroenteritis toxica
Similar endpoints
↥List of similar endpoints to
Toxic colitis
based on the number of shared cases.
Similar with more cases:
- Other noninfective gastroenteritis and colitis
- Noninfective enteritis and colitis
- Gastrointestinal diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 111 | 59 | 52 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 55.78 | 47.20 | 65.51 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 103
- Matched controls
- 1029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K52.1
ICD-10 Finland
Toxic gastroenteritis and colitis
+∞
148.5
103
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
21.6
20
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
130.4
20.4
21
*
A07EC02
ATC
mesalazine; oral, rectal
58.5
20.2
23
5
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
14.9
14
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
+∞
14.9
14
*
K51.5
ICD-10 Finland
Left sided colitis
+∞
13.9
13
*
130
Kela drug reimbursment
Malignant tumour
10.0
13.6
28
37
UJF32
NOMESCO Finland
Coloscopy
5.3
13.4
52
166
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
12.8
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
12.7
47
140
JN4BD
NOMESCO Finland
Extensive body CT
7.0
12.1
32
62
A04AA02
ATC
granisetron; systemic, transdermal
10.1
11.9
24
30
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.5
11.7
20
18
A07EA02
ATC
hydrocortisone; rectal
121.9
10.6
11
*
H02AB06
ATC
prednisolone; systemic
4.0
10.2
66
319
H02AB02
ATC
dexamethasone; systemic
6.1
10.1
29
62
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
7.5
10.0
24
40
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
9.8
19
22
ZX120
NOMESCO Finland
Intravenous
6.6
9.2
24
45
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.2
8.8
24
48
A02BC02
ATC
pantoprazole; systemic
4.0
8.5
82
509
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.6
8.5
32
92
TPX10
NOMESCO Finland
Implantation of vascular injection port
16.3
8.5
13
9
JN4AD
NOMESCO Finland
Body CT examination
6.5
8.5
22
41
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
8.1
33
102
L01BC06
ATC
capecitabine; oral
10.8
8.1
15
16
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
16.7
7.9
12
8
A07EA06
ATC
budesonide; oral, local oral
20.3
7.8
11
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
7.6
45
188
L04AX01
ATC
azathioprine; systemic
17.4
7.4
11
7
UJF30
NOMESCO Finland
Ileoscopy through colon
5.5
6.9
20
43
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
43.0
6.9
8
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.6
6.8
17
30
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.5
6.8
11
9
Z51.5
ICD-10 Finland
Palliative care
6.3
6.7
17
31
P01AB01
ATC
metronidazole; oral, rectal
3.0
6.4
52
263
B01AB05
ATC
enoxaparin; parenteral
3.1
6.2
42
189
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
6.2
24
70
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.2
6.1
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
50
12.42
33.59
2.1
1.5
—
—
—
0
0
19
20
11.26
16.60
1.3
1.2
—
—
—
0
0
37
89
5.74
15.60
6.4
4.3
29.50
8.24
ug/l
0.77
32
70
90
507
5.10
11.64
22.9
9.7
4.20
4.06
e9/l
0.22
84
449
44
152
4.14
11.48
8.9
2.6
0.79
0.83
mmol/l
1.97
44
142
70
355
3.63
9.95
13.4
4.2
32.72
36.01
g/l
3.30
70
337
78
455
3.40
8.26
19.9
5.6
10.80
10.96
umol/l
0.06
78
432
70
389
3.16
7.94
13.6
7.2
1.20
1.21
mmol/l
1.44
64
331
66
355
3.12
7.93
11.3
5.8
1.20
1.22
mmol/l
1.36
66
327
60
312
3.01
7.56
4.0
3.0
—
—
—
0
0
19
49
4.47
7.05
1.7
1.3
—
—
—
0
0
31
117
3.29
6.70
10.9
6.1
1.01
1.05
mmol/l
0.33
31
107
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
20
6.00
5.93
3.9
2.0
0.25
0.39
u/ml
—
5
10
10
17
6.37
5.73
3.3
1.4
—
—
—
0
0
33
146
2.79
5.31
2.8
1.7
—
—
—
0
0
25
98
3.00
4.98
2.6
1.5
—
—
—
0
0
35
165
2.64
4.94
4.3
3.1
45.50
105.66
ng/l
0.64
26
120
25
101
2.90
4.71
2.8
1.5
—
—
—
0
0
27
114
2.81
4.69
3.1
2.3
24.71
21.30
%
0.40
22
96
43
230
2.42
4.62
3.4
3.9
0.00
0.00
estimate
0.00
15
77
26
109
2.81
4.57
9.8
6.8
104.31
103.94
mmol/l
0.14
26
101
11
26
4.59
4.47
1.2
1.1
—
—
—
0
0
11
26
4.59
4.47
1.2
1.1
—
—
—
0
0
10
23
4.68
4.18
3.6
1.4
—
—
—
0
0
10
23
4.68
4.18
3.6
1.4
—
—
—
0
0
30
142
2.52
4.14
3.9
2.4
2.00
2.12
e6/l
0.05
21
77
22
94
2.67
3.70
3.9
2.0
31.09
28.45
u/l
0.28
22
77
63
424
2.12
3.68
4.3
3.8
0.00
0.00
estimate
0.00
15
80
63
428
2.09
3.54
5.6
5.3
0.00
0.00
estimate
0.00
14
80
6
6
10.47
3.54
3.0
1.5
—
—
—
0
0
63
437
2.02
3.25
4.3
3.8
0.00
0.00
estimate
0.00
15
82
14
51
3.00
3.12
1.1
1.3
—
—
—
0
0
7
12
6.14
3.07
1.4
1.4
—
—
—
0
0
30
161
2.18
3.05
3.9
2.3
0.65
0.90
e6/l
0.38
21
94
5
5
10.38
3.00
1.4
1.4
—
—
—
0
0
11
36
3.28
2.90
2.0
1.9
—
—
—
0
0
50
331
1.93
2.85
3.8
4.0
—
—
—
0
0
10
31
3.45
2.85
3.0
2.1
—
—
—
0
0
84
665
2.08
2.79
5.7
3.9
13.40
12.30
mm/h
0.28
78
610
12
43
3.01
2.74
6.5
5.2
23.42
25.49
mmol/l
0.83
12
43
9
24
3.99
2.74
1.3
1.6
—
—
—
0
0
8
19
4.45
2.73
4.0
1.3
—
—
—
0
0
6
11
5.69
2.58
4.7
3.7
2.43
3.95
nmol/l
—
6
11
6
13
4.81
2.30
3.0
1.5
—
—
—
0
0
34
211
1.88
2.28
1.6
1.5
20.67
20.33
nmol/l
0.04
34
187
5
9
5.75
2.23
1.6
1.2
—
—
—
0
0
5
9
5.75
2.23
1.4
1.6
—
—
—
0
0
13
55
2.54
2.22
5.8
3.7
118.77
129.75
g/l
0.86
13
55
7
19
3.86
2.19
2.9
1.4
—
—
—
0
0
6
14
4.46
2.18
3.5
1.2
—
—
—
0
0
11
44
2.67
2.08
2.1
1.7
—
—
—
0
0
54
394
1.72
2.08
8.8
3.9
—
—
—
0
0
49
348
1.73
2.08
2.0
1.9
94.16
93.75
pmol/l
0.02
31
180
100
881
2.36
2.01
41.5
13.3
25.08
22.70
mg/l
0.35
93
676
11
45
2.60
2.00
3.1
3.9
41.78
56.17
%
1.20
11
45
11
45
2.60
2.00
6.8
4.3
24.31
24.50
mmol/l
0.09
11
45
6
16
3.90
1.96
3.2
1.4
—
—
—
0
0
6
16
3.90
1.96
3.2
1.3
—
—
—
0
0
5
11
4.70
1.96
4.6
1.3
—
—
—
0
0
5
12
4.31
1.84
3.4
1.6
—
—
—
0
0
88
751
1.83
1.80
44.4
16.5
14.36
13.63
%
3.72
88
737
28
177
1.78
1.74
1.5
1.8
368.22
442.55
pmol/l
1.25
23
148
11
49
2.38
1.70
2.5
2.8
1.22
1.27
%
0.09
11
49
6
19
3.28
1.68
2.3
1.3
—
—
—
0
0
5
14
3.69
1.63
2.6
1.6
—
—
—
0
0
5
14
3.69
1.63
3.4
1.3
—
—
—
0
0
16
87
1.98
1.55
13.7
7.9
—
—
—
0
0
5
15
3.44
1.54
8.8
2.1
67.40
61.53
%
—
5
15
5
17
3.03
1.37
1.0
1.4
—
—
—
0
0
5
17
3.03
1.37
3.6
1.4
—
—
—
0
0
8
36
2.31
1.27
9.4
10.1
22.15
25.66
mmol/l
—
8
30
25
167
1.64
1.27
1.3
1.5
—
—
—
0
0
28
194
1.59
1.23
4.7
2.1
—
—
—
0
0
101
934
1.90
1.12
42.1
15.4
81.59
78.93
umol/l
0.18
101
934
90
809
1.59
1.10
38.8
14.2
37.06
40.22
%
1.89
62
607
98
901
1.75
1.07
39.9
15.0
139.16
139.79
mmol/l
1.88
98
880
43
338
1.44
1.04
4.3
3.8
17.64
45.38
ng/l
1.64
35
227
98
905
1.71
1.00
40.7
14.9
3.96
3.98
mmol/l
0.33
98
883
6
33
1.86
0.80
2.2
1.9
—
—
—
0
0
6
34
1.81
0.77
3.2
2.0
—
—
—
0
0
33
260
1.38
0.77
3.5
3.8
5.18
7.94
mg/mmol
0.51
24
166
9
55
1.69
0.76
2.3
3.0
4.37
4.48
pmol/l
—
9
50
5
25
2.05
0.73
1.4
1.1
—
—
—
0
0
5
27
1.89
0.69
1.0
1.4
—
—
—
0
0
83
891
0.73
0.68
4.5
4.8
2.54
2.72
mmol/l
1.05
74
821
5
28
1.82
0.67
1.0
1.2
—
—
—
0
0
8
49
1.68
0.64
1.3
2.0
—
—
—
0
0
81
867
0.76
0.58
4.2
4.3
1.30
1.46
mmol/l
3.38
72
801
9
59
1.57
0.56
1.3
2.1
—
—
—
0
0
88
825
1.32
0.52
5.0
4.5
1.93
1.90
mu/l
0.10
82
751
24
192
1.32
0.50
1.5
1.3
9.50
0.91
u/ml
—
8
52
88
827
1.31
0.49
32.6
12.1
81.03
81.87
ml/min/173m2
0.12
74
671
63
571
1.24
0.48
3.1
3.1
—
—
—
0
0
12
86
1.44
0.47
7.0
2.7
—
—
—
0
0
102
984
1.45
0.46
55.1
19.8
128.33
135.53
g/l
4.59
102
969
78
831
0.79
0.46
4.1
3.9
1.79
1.29
mmol/l
0.66
70
763
5
35
1.45
0.40
1.2
1.4
36.46
22.88
iu/l
—
5
30
83
871
0.81
0.36
4.2
4.3
4.46
4.61
mmol/l
0.35
73
812
23
265
0.83
0.28
5.7
4.4
20.55
21.98
%
0.23
13
119
12
149
0.78
0.28
1.4
1.3
1.42
8.79
u/ml
—
5
63
0
11
0.00
0.21
0.0
1.0
—
43.33
—
0
6
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
8
76
1.06
0.07
1.3
2.1
6.45
12.83
nmol/l
—
8
71
84
854
0.93
0.07
4.7
4.4
6.31
5.91
mmol/l
1.49
77
786
13
137
0.94
0.01
1.4
1.4
—
—
—
0
0
10
105
0.95
0.00
2.5
2.3
—
—
—
0
0
10
96
1.05
0.00
2.1
2.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
800.43
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
9.63
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: COLITTOX – Toxic colitis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).